These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 14579916)

  • 21. Association between brachial-ankle pulse wave velocity and the ratio of l-arginine to asymmetric dimethylarginine in patients undergoing coronary angiography.
    Masaki N; Hakuno D; Toya T; Shiraishi Y; Kujiraoka T; Namba T; Yada H; Kimura K; Miyazaki K; Adachi T
    J Cardiol; 2015 Apr; 65(4):311-7. PubMed ID: 25043133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parental history of premature coronary artery disease does not affect plasma levels of asymmetric dimethylarginine in young healthy adults.
    Surdacki A; Zawiślak B; Rakowski T; Wieczorek-Surdacka E; Fedak D; Dubiel JS
    Pol Arch Med Wewn; 2012; 122(10):487-93. PubMed ID: 23022711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).
    Meinitzer A; Seelhorst U; Wellnitz B; Halwachs-Baumann G; Boehm BO; Winkelmann BR; März W
    Clin Chem; 2007 Feb; 53(2):273-83. PubMed ID: 17185364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ratio Of Serum Asymmetric Dimethyl Arginine (ADMA)/ Nitric Oxide in Coronary Artery Disease patients.
    Shivkar RR; Abhang SA
    J Clin Diagn Res; 2014 Aug; 8(8):CC04-6. PubMed ID: 25302189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease.
    Parikh RV; Pargaonkar V; Ball RL; Kobayashi Y; Kimura T; Yeung AC; Cooke JP; Tremmel JA
    Int J Cardiol; 2020 Jan; 299():7-11. PubMed ID: 31416658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between plasma asymmetrical dimethylarginine activity and saphenous vein graft disease in patients with coronary bypass.
    Cagirci G; Cay S; Karakurt O; Buyukterzi Z; Yazihan N; Kilic H; Topaloglu S; Aras D; Akdemir R
    Coron Artery Dis; 2010 Jan; 21(1):20-5. PubMed ID: 19996737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients.
    Turiel M; Atzeni F; Tomasoni L; de Portu S; Delfino L; Bodini BD; Longhi M; Sitia S; Bianchi M; Ferrario P; Doria A; De Gennaro Colonna V; Sarzi-Puttini P
    Rheumatology (Oxford); 2009 Jul; 48(7):834-9. PubMed ID: 19465588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plasma asymmetric dimethylarginine and cystatin C levels in patients with coronary artery disease].
    YOU L; ZHAO CX; SHAO JM; ZHANG L; WANG DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):798-800. PubMed ID: 21092647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detrimental effects of a bout of physical exercise on circulating endogenous inhibitors of endothelial function in patients with coronary artery disease.
    Ilic MD; Pavlovic R; Lazarevic G; Zivanovic S; Cvetkovic T; Kocic G; Ilic S; Ambrosio G
    J Cardiovasc Med (Hagerstown); 2017 Aug; 18(8):610-616. PubMed ID: 27168139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal asymmetric dimethylarginine/nitric oxide balance in patients with documented coronary artery disease: relation to renal function and homocysteine.
    Ilhan N; Seckin D; Ilhan N; Ozbay Y
    J Thromb Thrombolysis; 2007 Jun; 23(3):205-11. PubMed ID: 17160550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of coronary revascularization with or without cardiopulmonary bypass on plasma levels of asymmetric dimethylarginine.
    Cziráki A; Ajtay Z; Németh Á; Lenkey Z; Sulyok E; Szabados S; Alotti N; Martens-Lobenhoffer J; Szabó C; Bode-Böger SM
    Coron Artery Dis; 2011 Jun; 22(4):245-52. PubMed ID: 21383621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
    Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
    Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance.
    Surdacki A; Stochmal E; Szurkowska M; Bode-Böger SM; Martens-Lobenhoffer J; Stochmal A; Klecha A; Kawecka-Jaszcz K; Dubiel JS; Huszno B; Szybiński Z
    Metabolism; 2007 Jan; 56(1):77-86. PubMed ID: 17161229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between coronary atherosclerotic burden and asymmetric dimethylarginine, carotis intima media thickness and endothelial function.
    Can F; Ziyrek M; Erdem Ş; Civan M; Görmüş U; Şahin S; Acar Z; Çiftçi Ç
    Turk Kardiyol Dern Ars; 2014 Dec; 42(8):701-9. PubMed ID: 25620330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stent placement in patients with coronary heart disease decreases plasma levels of the endogenous nitric oxide synthase inhibitor ADMA.
    Ajtay Z; Scalera F; Cziráki A; Horváth I; Papp L; Sulyok E; Szabo C; Martens-Lobenhoffer J; Awiszus F; Bode-Böger SM
    Int J Mol Med; 2009 May; 23(5):651-7. PubMed ID: 19360324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.
    Miyazaki H; Matsuoka H; Cooke JP; Usui M; Ueda S; Okuda S; Imaizumi T
    Circulation; 1999 Mar; 99(9):1141-6. PubMed ID: 10069780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization.
    Frøbert O; Hjortshøj SP; Simonsen U; Ravkilde J
    Int J Cardiol; 2008 Sep; 129(2):288-91. PubMed ID: 17689741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease.
    Morisawa T; Nakagomi A; Kohashi K; Kosugi M; Kusama Y; Atarashi H; Shimizu W
    Int Heart J; 2015; 56(6):605-12. PubMed ID: 26549398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
    Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM
    Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
    Yucel H; Ozaydin M; Dogan A; Erdogan D; Turker Y; Ceyhan BM; Sutcu R
    Scand J Clin Lab Invest; 2012 Oct; 72(6):495-500. PubMed ID: 22950626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.